Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88452418 | FILING DATE | 05/30/2019 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | AURAND, KYLE C |
L.O. ASSIGNED | N80-NOT FOUND |
PUB INFORMATION |
|||
RUN DATE | 02/21/2020 | ||
PUB DATE | N/A | ||
STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
STATUS DATE | 02/20/2020 | ||
LITERAL MARK ELEMENT | EPIZYME | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | YES | 1 (a) | YES | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | EPIZYME |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Epizyme, Inc. |
ADDRESS | 400 Technology Square Cambridge, MA 02319 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | pharmaceutical products for the treatment of human diseases and disorders, namely, cancer, cell proliferative diseases and disorders, hematological diseases and disorders, genetic diseases and disorders, and diseases and disorders driven by epigenetic mechanisms |
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | pharmaceutical research and development in the fields of cancer, cell proliferative diseases and disorders, hematological diseases and disorders, genetic diseases and disorders, and diseases and disorders driven by epigenetic mechanisms; all of the foregoing for human medicinal purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 042 | FIRST USE DATE | 09/00/2008 | FIRST USE IN COMMERCE DATE | 09/00/2008 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
02/20/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 014 |
02/20/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 013 |
02/20/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 012 |
02/20/2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 011 |
02/20/2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 010 |
02/20/2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 009 |
02/20/2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 008 |
02/20/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
08/21/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
08/21/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
08/21/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
08/20/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
06/13/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
06/03/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Douglas R. Wolf |
CORRESPONDENCE ADDRESS | Douglas R. Wolf WOLF, GREENFIELD & SACKS, P.C. 600 ATLANTIC AVENUE BOSTON MA 02210 |
DOMESTIC REPRESENTATIVE | NONE |